WallStreetZenWallStreetZen

NASDAQ: COLL
Collegium Pharmaceutical Inc Stock Ownership - Who owns Collegium Pharmaceutical?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Collegium Pharmaceutical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David DieterEVP General Counsel2026-03-1813,976$34.92
$488.10kSell
David DieterEVP General Counsel2026-03-178,840$35.72
$315.76kSell
David DieterEVP General Counsel2026-03-096,224$36.65
$228.11kSell
Scott DreyerEVP Chief Commercial Officer2026-03-033,559$40.99
$145.88kSell
Scott DreyerEVP Chief Commercial Officer2026-03-0346,417$40.36
$1.87MSell
Vikram KarnaniPresident and CEO2026-02-1011,296$46.75
$528.09kSell
Thomas B. SmithEVP and Chief Medical Officer2026-02-105,897$46.75
$275.68kSell
David DieterEVP General Counsel2026-02-102,781$46.75
$130.01kSell
Colleen TupperEVP Chief Financial Officer2026-02-1026,679$46.75
$1.25MSell
Colleen TupperEVP Chief Financial Officer2026-02-1011,861$46.75
$554.50kSell

1 of 4

COLL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COLL insiders and whales buy or sell their stock.

COLL Shareholders

What type of owners hold Collegium Pharmaceutical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David Hirsch20.28%6,438,798$222.65MInsider
Rubric Capital Management LP19.81%6,290,486$217.53MInsider
Longitude Capital Partners LLC17.77%5,643,684$195.16MInsider
Skyline Venture Partners V LP16.06%5,099,832$176.35MInsider
Blackrock Inc16.06%5,099,702$176.35MInstitution
Vanguard Group Inc7.11%2,256,254$78.02MInstitution
Yasunori Kaneko6.77%2,150,186$74.35MInsider
Patrick J. Heron5.94%1,887,332$65.26MInsider
Frazier Healthcare VI LP5.94%1,887,332$65.26MInsider
Eventide Asset Management LLC5.91%1,876,239$64.88MInstitution

1 of 3

COLL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COLL51.97%48.03%Net SellingNet Selling
EVO5.54%0.00%
ALVO4.99%0.00%
AMPH48.75%51.25%Net BuyingNet Selling
CRON13.75%49.84%Net SellingNet Selling
View Top Pharmaceutical Stocks

Collegium Pharmaceutical Stock Ownership FAQ

Who owns Collegium Pharmaceutical?

Collegium Pharmaceutical (NASDAQ: COLL) is owned by 116.92% institutional shareholders, 108.05% Collegium Pharmaceutical insiders, and 0.00% retail investors. David Hirsch is the largest individual Collegium Pharmaceutical shareholder, owning 6.44M shares representing 20.28% of the company. David Hirsch's Collegium Pharmaceutical shares are currently valued at $227.42M.

If you're new to stock investing, here's how to buy Collegium Pharmaceutical stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.